ReviewThe Prostate2022

Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins.

Joakin O Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.